ATC code H04
ATC code H04 Pancreatic hormones is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup H04 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[3]
ATC codes |
---|
H Systemic hormonal preparations, excluding sex hormones and insulins |
H01 Pituitary and hypothalamic hormones and analogues |
H02 Corticosteroids for systemic use |
H03 Thyroid therapy |
H04 Pancreatic hormones |
H05 Calcium homeostasis |
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH04.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H04A Glycogenolytic hormones
H04AA Glycogenolytic hormones
- H04AA01 Glucagon
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- "ATC/DDD Index 2021: code H04". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2021: code QH04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.